SEC Filing Summary: Bioptix, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bioptix, Inc. on May 25, 2017. The filing addresses the release of escrowed funds and securities from a private placement transaction originally executed on March 10, 2017. Note: The request metadata referenced "Riot Platforms, Inc.", but the source text explicitly identifies the registrant as Bioptix, Inc.
Key Financial Metrics and Transaction Details
- Total Private Placement Size: $2.25 million in Units sold at $2.50 per Unit.
- Unit Composition: One share of Common Stock and a three-year warrant to purchase one share at $3.50 per share.
- Escrow Amount Released: $1.25 million in cash proceeds.
- Securities Released: Certificates representing 55.5556% of the Units sold.
- Liquidity Impact: Immediate increase in available cash of $1.25 million upon release from escrow.
Material Changes
The material change reported is the waiver of the "Qualified Transaction" requirement by the Lead Investor. Previously, $1.25 million of proceeds and the associated securities were held in escrow pending this condition. As of May 25, 2017, the condition was waived, resulting in the full release of the escrowed assets to the Company and the Investors.
Outlook, Risks, and Management Commentary
The filing does not provide forward-looking guidance, management commentary on future operations, or specific risk factors beyond the mechanics of the escrow release. The event is presented as a completed transactional milestone.
Key Facts for Investor Verification
- Verify the identity of the registrant as Bioptix, Inc., not Riot Platforms, Inc.
- Confirm the total capital raised ($2.25 million) and the portion previously held in escrow ($1.25 million).
- Review the terms of the warrants issued (3-year term, $3.50 exercise price).
- Understand that the release of funds was contingent on a waiver by the Lead Investor rather than the occurrence of a Qualified Transaction.